Patrick Twohig

GI & Transplant Hepatology Faculty @urmc. #meded #QI, Husband, father, sports & fitness fanatic, music enthusiast, tweets = own

[Patrick Twohig @2higMD]

#TLM23 @AmCollegeGastro @AASLDtweets @BeeThoetchai @URMC_DeptMed

[Patrick Twohig @2higMD]

🚨 Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic 🚨
📈 >60y, male, Hispanic patients most affected
✅ latest trends >Omicron

Article @DDS_Journal: https://t.co/xhtLnZQPjV
@UNMC_GIHEP @DDWMeeting

[Hepatology Communications @HepCommJournal]

📑 Alcohol-associated Hepatitis incidence is 📈 at an alarming rate!

Disproportionate 📈 especially among women and individuals of low socioeconomic status‼️🚨
#LiverTwitter #OpenAccess

https://t.co/yzcJ9PJT7Q

[Hepatology Communications @HepCommJournal]

📑 Increased accuracy in identifying #NAFLD with advanced fibrosis and cirrhosis!

⭐️ Agile 3+ & 4 scores performed superiorly to FIB-4 & LSM by VCTE & maintained good accuracy for diagnosis of adv fibrosis and cirrhosis!
#LiverTwitter

https://t.co/DYaokYkCWL

[roypounder.apt @APandT]

Improved health-related quality of life with semaglutide in people with non-alcoholic steatohepatitis: A randomised trial #LiverTwitter #NAFLD #NASH #semaglutide https://t.co/BESXEYHaAJ

[Katie Hutchins, MD @kehutchins77]

Graduation for @UNMC_GIHEP

A sprinkle of 😢 but overwhelming happiness and pride.

Congratulations. Go change the 🌎
You’ve got a lot of ❤️

@UNMC_IM #UNMCIM

[Katie Hutchins, MD @kehutchins77]

It’s graduation time 🎓

Celebrating the inaugural HEAL class under the leadership of @CoryRohlfsen

Well done Dr Patrick Twohig and Dr Tomoki Sempokuya!

#HealthEducatorsAcademicLeaders
#UNMCIM

[Amit G Singal @docamitgs]

New @AASLDtweets guidance for #HCC should be online at @HEP_Journal soon!

Honored to have worked with fantastic multi-D author group, reflecting increasingly complex management.

https://t.co/RrwqRg0Nwj

[Carl Kay, MD @CarlKayMD]

Top 10 Do & Don’ts in Liver Dz @ebtapper

1️⃣Nutrition (1gm/kg protein / day)
2️⃣Exercise (https://t.co/6852Q2bCpO)
3️⃣Pre-op (VOCAL-Penn)
4️⃣PEth
5️⃣Naltrexone 50 mg
6️⃣Carvedilol 12.5 mg daily
7️⃣Educate
8️⃣Symptoms
9️⃣Depression
🔟Mix Lactulose

#DDW2023 #GITwitter

[AASLD Foundation @AASLDFoundation]

Congratulations to Patrick Twohig, MD, MPH on his Fellow Abstract Award! Patrick will present his award-winning abstract at @DDWMeeting May 6-9, 2023. https://t.co/KFuOuf2O1G
#LiverTwitter #DDW2023 @2higMD

[Patrick Twohig @2higMD]

Thank you! @AASLDtweets @AASLDFoundation @DDWMeeting

[AASLD Foundation @AASLDFoundation]

Congratulations to our AASLD Foundation #DDW2023 abstract awardees! @DDWMeeting #LiverTwitter https://t.co/KFuOuf2O1G

[Patrick Twohig @2higMD]

Thank you @AASLDFoundation @AASLDtweets for the abstract 🏆 and poster of distinction🏅Looking fwd to highlighting the prevalence of NAFLD in Turner Syndrome @DDWMeeting !! Grateful for the ongoing support of mentors + co-authors 🤝

[Katie Hutchins, MD @kehutchins77]

Hands-on session at @UNMC_iEXCEL SIM lab for @UNMC_GIHEP fellows.

👏🏻 👏🏻👏🏻 bravo to these superstars 🌟
#Blakemore

@UNMC_IM
@AmCollegeGastro @AmerGastroAssn @ASGEendoscopy

#FutureOfGI #GITwitter

[Patrick Twohig @2higMD]

🚨 How to incorporate addiction training into GI/hepatology fellowships 🚨

Check out our editorial to this great article by @lykhaque, citing innovative work by @geneyim, the @AASLDtweets @UNMC_GIHEP @AmCollegeGastro

🔥 off the press in @DDS_Journal https://t.co/6poovozZn6

[Patrick Twohig @2higMD]

Proud to present our teams study on the benefits of treating alcohol use disorder among hospitalized patients with liver disease:
-5-fold ⬇️ risk of 1y ⚰️
-⬇️ age, consult with GI/Hep/psych, brief counseling are all ➕ predictors

@AASLDtweets #TLM22 @NIAAAnews

[UNMC Gastroenterology & Hepatology @UNMC_GIHEP]

Keep shining @2higMD 🌞🌞🌞🌞 our superstar GI/Hep fellow Dr. Twohig presenting his work on alcohol associated liver disease @AASLDFoundation🎉🎉🎉 @UNMC_IM @AmerGastroAssn @AmCollegeGastro #GITwitter #MedTwitter

[Patrick Twohig @2higMD]

I pushed back on PBC at the Intercept Booth #549 at THE LIVER MEETING®. #PushBackOnPBC #TLMDx ⁦@AASLDtweets⁩ https://t.co/wNmG7kB88c

[Patrick Twohig @2higMD]

Spironolactone as a 💊 for alcohol use disorder? This study in @molpsychiatry found in decreased consumption rates in both mouse and human models 🤯 @DrPsychMD @BeeThoetchai @NIAAAnews

[Rahul Ganatra @rbganatra]

This is farther away from prime time than the title suggests, but is a really fascinating hypothesis:

Spironolactone reduces alcohol consumption in rats.

Could mineralocorticoid antagonism one day be a treatment for alcohol use disorder?

https://t.co/cGA4x2pqI9

[Patrick Twohig @2higMD]

Thank you @AST_info for a highly educational #ASTFellows2022! 👏 ⬆️ Networking, ⬆️ knowledge, and all things #transplant #livertwitter

[Digestive Diseases and Sciences @DDS_Journal]

Recent illicit drug use: Scope or not scope? @2higMD et al found that cancelling endoscopy without considering drug type, dose, and chronicity can unnecessarily delay care and ↑morbidity. Standardized guidelines needed! Read more https://t.co/aw8aWmHVJz #SpringerNature

[Patrick Twohig @2higMD]

Recent illicit drug use: Scope or not? We found that cancelling endoscopy without considering drug type, dose, and chronicity can unnecessarily delay care and ↑morbidity. Guidelines needed! @DDS_Journal https://t.co/vo6zpqlJva